Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Schering AG acquires rights to fasudil in the U.S. and Europe

Aug. 10, 2001

Selective PDE5 inhibitors reported by scientists at Nippon Soda

Aug. 8, 2001

Mitsui Chemicals reports anilide derivatives useful as antiarrhythmic agents

Aug. 8, 2001

Novel caspase inhibitors patented by Vertex

Aug. 7, 2001

YM-471 shows potent affinity and selectivity for human vasopressin V1A and V2 receptors

Aug. 7, 2001

Chronic dronedarone differs strongly from chronic amiodarone in the canine heart

Aug. 7, 2001

FDA places TP-10 pediatric trials on hold

Aug. 7, 2001

Arrhythmogenicity of nesiritide and dobutamine compared in CHF patients

Aug. 6, 2001

Phase I safety study of RSD-1235 for atrial fibrillation reveals promising results

Aug. 2, 2001

Melanocortin peptides protect against myocardial ischemia in animals

July 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...